The Senate won’t vote until early next year on a bill to loosen restrictions on publicly funded embryonic stem cell studies, under a deal struck Friday by the sponsors.

“The majority leader has committed to bringing it up as one of the first items next year,” Sen. Arlen Specter, R-Pa., the stem cell bill’s lead sponsor, announced on the Senate floor.